David J Mauro
CIK 1621172 · View on SEC EDGAR ↗
Insider
First SEC filing: June 7, 2023 · Latest: June 7, 2023
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 27 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
27 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 5, 2021 | PRLD | S 10b5-1 | 1,289 | $32.06 | $41,325 | 0 Direct | -100.00% | Disposed | -81.8% (price as of 2026-08-20) |
| Oct. 5, 2021 | PRLD | S 10b5-1 | 7,803 | $31.30 | $244,234 | 1,289 Direct | -85.82% | Disposed | -81.3% (price as of 2026-08-20) |
| Oct. 5, 2021 | PRLD | S 10b5-1 | 5,908 | $30.26 | $178,776 | 9,092 Direct | -39.39% | Disposed | -80.7% (price as of 2026-08-20) |
| Sept. 7, 2021 | PRLD | S 10b5-1 | 4,640 | $37.79 | $175,346 | 0 Direct | -100.00% | Disposed | -84.5% (price as of 2026-08-20) |
| Sept. 7, 2021 | PRLD | S 10b5-1 | 2,873 | $36.92 | $106,071 | 4,640 Direct | -38.24% | Disposed | -84.2% (price as of 2026-08-20) |
| Sept. 7, 2021 | PRLD | S 10b5-1 | 7,487 | $35.91 | $268,858 | 7,513 Direct | -49.91% | Disposed | -83.7% (price as of 2026-08-20) |
| Aug. 5, 2021 | PRLD | S 10b5-1 | 100 | $32.63 | $3,263 | 0 Direct | -100.00% | Disposed | -82.1% (price as of 2026-08-20) |
| Aug. 5, 2021 | PRLD | S 10b5-1 | 6,721 | $32.15 | $216,080 | 100 Direct | -98.53% | Disposed | -81.8% (price as of 2026-08-20) |
| Aug. 5, 2021 | PRLD | S 10b5-1 | 2,063 | $31.03 | $64,015 | 6,821 Direct | -23.22% | Disposed | -81.2% (price as of 2026-08-20) |
| Aug. 5, 2021 | PRLD | S 10b5-1 | 6,116 | $29.93 | $183,052 | 8,884 Direct | -40.77% | Disposed | -80.5% (price as of 2026-08-20) |
| July 6, 2021 | PRLD | S 10b5-1 | 300 | $28.84 | $8,652 | 0 Direct | -100.00% | Disposed | -79.8% (price as of 2026-08-20) |
| July 6, 2021 | PRLD | S 10b5-1 | 4,255 | $28.13 | $119,693 | 300 Direct | -93.41% | Disposed | -79.2% (price as of 2026-08-20) |
| July 6, 2021 | PRLD | S 10b5-1 | 10,445 | $27.17 | $283,791 | 4,555 Direct | -69.63% | Disposed | -78.5% (price as of 2026-08-20) |
| June 7, 2021 | PRLD | S 10b5-1 | 12,700 | $32.73 | $415,671 | 0 Direct | -100.00% | Disposed | -82.2% (price as of 2026-08-20) |
| June 7, 2021 | PRLD | S 10b5-1 | 900 | $31.62 | $28,458 | 12,700 Direct | -6.62% | Disposed | -81.5% (price as of 2026-08-20) |
| June 7, 2021 | PRLD | S 10b5-1 | 1,400 | $30.35 | $42,490 | 13,600 Direct | -9.33% | Disposed | -80.8% (price as of 2026-08-20) |
| May 5, 2021 | PRLD | S 10b5-1 | 1,109 | $41.07 | $45,547 | 0 Direct | -100.00% | Disposed | -85.8% (price as of 2026-08-20) |
| May 5, 2021 | PRLD | S 10b5-1 | 10,476 | $40.30 | $422,183 | 1,109 Direct | -90.43% | Disposed | -85.5% (price as of 2026-08-20) |
| May 5, 2021 | PRLD | S 10b5-1 | 3,415 | $39.36 | $134,414 | 11,585 Direct | -22.77% | Disposed | -85.2% (price as of 2026-08-20) |
| April 27, 2021 | PRLD | S 10b5-1 | 1,711 | $36.11 | $61,784 | 0 Direct | -100.00% | Disposed | -83.8% (price as of 2026-08-20) |
| April 27, 2021 | PRLD | S 10b5-1 | 15,601 | $35.68 | $556,644 | 1,711 Direct | -90.12% | Disposed | -83.6% (price as of 2026-08-20) |
| April 27, 2021 | PRLD | S 10b5-1 | 7,688 | $34.66 | $266,466 | 17,312 Direct | -30.75% | Disposed | -83.2% (price as of 2026-08-20) |
| April 19, 2021 | PRLD | S 10b5-1 | 4,000 | $31.27 | $125,080 | 0 Direct | -100.00% | Disposed | -81.3% (price as of 2026-08-20) |
| April 19, 2021 | PRLD | S 10b5-1 | 21,000 | $30.82 | $647,220 | 4,000 Direct | -84.00% | Disposed | -81.1% (price as of 2026-08-20) |
| April 8, 2021 | PRLD | S 10b5-1 | 3,549 | $39.56 | $140,398 | 0 Direct | -100.00% | Disposed | -85.2% (price as of 2026-08-20) |
| April 8, 2021 | PRLD | S 10b5-1 | 1,293 | $39.00 | $50,427 | 3,549 Direct | -26.70% | Disposed | -85.0% (price as of 2026-08-20) |
| April 8, 2021 | PRLD | S 10b5-1 | 1,501 | $37.83 | $56,783 | 4,842 Direct | -23.66% | Disposed | -84.6% (price as of 2026-08-20) |
| April 8, 2021 | PRLD | S 10b5-1 | 3,274 | $37.04 | $121,269 | 6,343 Direct | -34.04% | Disposed | -84.2% (price as of 2026-08-20) |
| April 7, 2021 | PRLD | S 10b5-1 | 7,083 | $39.69 | $281,124 | 0 Direct | -100.00% | Disposed | -85.3% (price as of 2026-08-20) |
| April 7, 2021 | PRLD | S 10b5-1 | 8,300 | $39.02 | $323,866 | 7,083 Direct | -53.96% | Disposed | -85.0% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 9, 2024 | RXRX | Stock Option (RIght to Buy) | Class A Common Stock (99,537) | $10.09 | Feb. 9, 2034 | 99,537 | Acquired |
| June 1, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock (381,426) | $8.77 | June 1, 2033 | 381,426 | Acquired |
| Oct. 5, 2021 | PRLD | Employee Stock Option (Right to Buy) | Common Stock (15,000) | $1.89 | July 17, 2029 | 15,000 | Disposed |
| Sept. 7, 2021 | PRLD | Employee Stock Option (Right to Buy) | Common Stock (15,000) | $1.89 | July 17, 2029 | 15,000 | Disposed |
| Aug. 5, 2021 | PRLD | Employee Stock Option (Right to Buy) | Common Stock (15,000) | $1.89 | July 17, 2029 | 15,000 | Disposed |
| July 20, 2021 | PRLD | Employee Stock Option (Right to Buy) | Common Stock (95,000) | $31.23 | July 19, 2031 | 95,000 | Acquired |
| July 6, 2021 | PRLD | Employee Stock Option (Right to Buy) | Common Stock (15,000) | $1.89 | July 17, 2029 | 15,000 | Disposed |
| June 7, 2021 | PRLD | Common Stock | Common Stock (15,000) | $1.89 | June 16, 2029 | 15,000 | Disposed |
| May 5, 2021 | PRLD | Common Stock | Common Stock (15,000) | $1.89 | June 16, 2029 | 15,000 | Disposed |
| April 27, 2021 | PRLD | Employee Stock Option (right to buy) | Common Stock (25,000) | $1.89 | June 16, 2029 | 25,000 | Disposed |
| April 19, 2021 | PRLD | Employee Stock Option (right to buy) | Common Stock (25,000) | $1.89 | June 16, 2029 | 25,000 | Disposed |
| April 8, 2021 | PRLD | Employee Stock Option (right to buy) | Common Stock (9,617) | $1.89 | June 16, 2029 | 9,617 | Disposed |
| April 7, 2021 | PRLD | Employee Stock Option (right to buy) | Common Stock (15,383) | $1.89 | June 16, 2029 | 15,383 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 7, 2023 | RXRX | No securities are beneficially owned. | 0 | Direct |
| Sept. 24, 2020 | PRLD | Employee Stock Option (right to buy)→ Common Stock (302,610) | 302,610 | Direct |
| Sept. 24, 2020 | PRLD | Employee Stock Option (right to buy)→ Common Stock (43,229) | 43,229 | Direct |
| Sept. 24, 2020 | PRLD | Employee Stock Option (right to buy)→ Common Stock (142,658) | 142,658 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
RXRX
Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $525,000 | — | $502,159 | $638,032 | $211,626 | — | $56,773 | $1,933,590 |
| 2023 | $303,333 | — | $1,672,553 | $2,181,756 | $121,634 | — | $33,190 | $4,312,466 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.